TokenPost topic

mRNA therapy

1 TokenPost story is tagged mRNA therapy. The newest appear first.

Latest mRNA therapy stories

• Moderna, Merck Find 42% Lower Melanoma Recurrence-or-Death Risk

  Estimated two-year recurrence-free survival was 82.2% with the combination and 70.0% with Keytruda alone; overall-survival data remain immature.

  Oct 23, 2026, 1:09 PM EDT · Business